Archive · 11 Sep 2026
Marengo Asia Hospitals Raises $40 Million For Healthcare Expansion
Marengo Asia Hospitals is a company that runs hospitals in India.
It raised $40 million from LeapFrog Investments to help it grow.
The company wants to expand into more large and mid-sized cities.
It will also spend money on medical equipment, specialist care, and better patient services.
Marengo currently operates five hospitals in India.
It also has a partnership in Saudi Arabia involving about 2,000 beds.
The company hopes to double its total number of beds to 4,000 within two years.
This expansion is intended to make advanced medical care easier to access outside India’s biggest cities.
Marengo Asia Hospitals raised $40 million in growth capital from LeapFrog Investments.
The company plans to expand in Tier I and Tier II cities and invest in medical technology, specialty centers, and patient experience.
Marengo operates five hospitals in India and has a Saudi Arabia partnership covering about 2,000 beds.
The company aims to double its hospital bed capacity to 4,000 beds over the next two years.
Marengo reported FY25 operating revenue of ₹811 crore, up from ₹695 crore the previous year.
- Who
- Marengo Asia Hospitals raised funds from LeapFrog Investments, with backing from Samara Capital and the family offices of the Godrej and Havells groups.
- What
- Marengo raised $40 million in growth capital for hospital expansion and healthcare investments.
- When
- The fundraising was announced on Friday; Marengo was established in 2021 and reported FY25 revenue figures.
- Where
- The expansion will focus on India, including existing markets, Tier I and Tier II cities, and adjacent geographies; the company also has a partnership in Saudi Arabia.
- Why
- The funds will support geographic expansion, medical technology, centers of excellence, patient experience, and the goal of reaching 4,000 hospital beds.
- Funding
- $40 million in growth capital
- Investor
- LeapFrog Investments
- Current Indian hospitals
- Five
- Planned capacity
- 4,000 beds within two years
- Saudi Arabia partnership
- About 2,000 beds and more than 900,000 patients served annually
- FY25 operating revenue
- ₹811 crore, compared with ₹695 crore a year earlier
- Transaction advisor
- Avendus Capital